GREENLAND MINES LTD Interest Income, Securities, US Treasury
GREENLAND MINES LTD (GRML) reported Interest Income, Securities, US Treasury of $57.81 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeSecuritiesUSTreasury · last filed 2023-11-17
- GREENLAND MINES LTD interest income, securities, us treasury for the quarter ending 2023-09-30 was $861.83K, a 176.05% increase year-over-year.
- GREENLAND MINES LTD interest income, securities, us treasury for the quarter ending 2023-06-30 was -$62.47M.
- GREENLAND MINES LTD interest income, securities, us treasury for the quarter ending 2023-03-31 was $119.42M.
- GREENLAND MINES LTD interest income, securities, us treasury for the quarter ending 2022-12-31 was $1.20M.
| Period end | Interest Income, Securities, US Treasury 3 month | Interest Income, Securities, US Treasury 6 month | Interest Income, Securities, US Treasury 9 month | Interest Income, Securities, US Treasury 12 month |
|---|---|---|---|---|
| 2023-09-30 | $861.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | -$61.60M derived: sum of 2 quarters · filed 2023-11-17 | $57.81M 10-Q · filed 2023-11-17 | $59.01M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | -$62.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $56.95M 10-Q · filed 2023-08-21 | $58.15M derived: sum of 3 quarters · filed 2023-11-17 | $58.46M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | $119.42M 10-Q · filed 2023-05-24 | $120.61M derived: sum of 2 quarters · filed 2023-11-17 | $120.93M derived: sum of 3 quarters · filed 2023-11-17 | |
| 2022-12-31 | $1.20M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-17 | $1.51M derived: sum of 2 quarters · filed 2023-11-17 | $117.81M 10-Q · filed 2023-11-17 | |
| 2022-09-30 | $312.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $116.61M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $116.30M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |